Validation

S6 no glucose, 1-12h 2mM-ACAIR=4
PARK, S., SCHEFFLER, T. L. & GERRARD, D. E. 2011. Chronic high cytosolic calcium decreases AICAR-induced AMPK activity via calcium/calmodulin activated protein kinase II signaling cascade. Cell Calcium, 50, 73-83.

S7
OUCHI, N., SHIBATA, R. & WALSH, K. 2005. AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle. Circ Res, 96, 838-46.

S8
EGAWA, T., OHNO, Y., GOTO, A., IKUTA, A., SUZUKI, M., OHIRA, T., YOKOYAMA, S., SUGIURA, T., OHIRA, Y., YOSHIOKA, T. & GOTO, K. 2014. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells. Am J Physiol Endocrinol Metab, 306, E344-54.

S9
HALL, D. T., GRISS, T., MA, J. F., SANCHEZ, B. J., SADEK, J., TREMBLAY, A. M. K., MUBAID, S., OMER, A., FORD, R. J., BEDARD, N., PAUSE, A., WING, S. S., DI MARCO, S., STEINBERG, G. R., JONES, R. G. & GALLOUZI, I. E. 2018. The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting. EMBO Mol Med, 10.

S10
CANTO, C., GERHART-HINES, Z., FEIGE, J. N., LAGOUGE, M., NORIEGA, L., MILNE, J. C., ELLIOTT, P. J., PUIGSERVER, P. & AUWERX, J. 2009. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature, 458, 1056-60.

S11
FULCO, M., CEN, Y., ZHAO, P., HOFFMAN, E. P., MCBURNEY, M. W., SAUVE, A. A. & SARTORELLI, V. 2008. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell, 14, 661-73.

S12
CANTO, C., GERHART-HINES, Z., FEIGE, J. N., LAGOUGE, M., NORIEGA, L., MILNE, J. C., ELLIOTT, P. J., PUIGSERVER, P. & AUWERX, J. 2009. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature, 458, 1056-60.

S13
PARK, C.-S., KIM, J.-H., OH, Y.-K., KIM, K., CHOI, C.-W., CHO, E.-S., JEONG, Y.-D. & PARK, S.-K. 2012. AICAR (5-aminoimidazole-4-carboxamide-1-?-D-ribonucleoside) Decreases Protein Synthesis in C2C12 Myotubes Cultured in High Glucose Media.

S14
GERHART-HINES, Z., RODGERS, J. T., BARE, O., LERIN, C., KIM, S. H., MOSTOSLAVSKY, R., ALT, F. W., WU, Z. & PUIGSERVER, P. 2007. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J, 26, 1913-23.

S15
FULCO, M., CEN, Y., ZHAO, P., HOFFMAN, E. P., MCBURNEY, M. W., SAUVE, A. A. & SARTORELLI, V. 2008. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell, 14, 661-73.

S16
CANTO, C., HOUTKOOPER, R. H., PIRINEN, E., YOUN, D. Y., OOSTERVEER, M. H., CEN, Y., FERNANDEZ-MARCOS, P. J., YAMAMOTO, H., ANDREUX, P. A., CETTOUR-ROSE, P., GADEMANN, K., RINSCH, C., SCHOONJANS, K., SAUVE, A. A. & AUWERX, J. 2012. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab, 15, 838-47.

S17
RYU, D., ZHANG, H., ROPELLE, E. R., SORRENTINO, V., MAZALA, D. A., MOUCHIROUD, L., MARSHALL, P. L., CAMPBELL, M. D., ALI, A. S., KNOWELS, G. M., BELLEMIN, S., IYER, S. R., WANG, X., GARIANI, K., SAUVE, A. A., CANTO, C., CONLEY, K. E., WALTER, L., LOVERING, R. M., CHIN, E. R., JASMIN, B. J., MARCINEK, D. J., MENZIES, K. J. & AUWERX, J. 2016. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation. Sci Transl Med, 8, 361ra139.

S18
FLETCHER, R. S., RATAJCZAK, J., DOIG, C. L., OAKEY, L. A., CALLINGHAM, R., DA SILVA XAVIER, G., GARTEN, A., ELHASSAN, Y. S., REDPATH, P., MIGAUD, M. E., PHILP, A., BRENNER, C., CANTO, C. & LAVERY, G. G. 2017. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. Mol Metab, 6, 819-832.

S19
HSU, C. G. & BURKHOLDER, T. J. 2016. Independent AMP and NAD signaling regulates C2C12 differentiation and metabolic adaptation. J Physiol Biochem, 72, 689-697.

S20
HIGASHIDA, K., KIM, S. H., JUNG, S. R., ASAKA, M., HOLLOSZY, J. O. & HAN, D. H. 2013. Effects of resveratrol and SIRT1 on PGC-1alpha activity and mitochondrial biogenesis: a reevaluation. PLoS Biol, 11, e1001603.

S21
FAKOURI, N. B., DURHUUS, J. A., REGNELL, C. E., ANGLEYS, M., DESLER, C., HASAN-OLIVE, M. M., MARTIN-PARDILLOS, A., TSAALBI-SHTYLIK, A., THOMSEN, K., LAURITZEN, M., BOHR, V. A., DE WIND, N., BERGERSEN, L. H. & RASMUSSEN, L. J. 2017. Rev1 contributes to proper mitochondrial function via the PARP-NAD(+)-SIRT1-PGC1alpha axis. Sci Rep, 7, 12480.

S22
HIGASHIDA, K., KIM, S. H., JUNG, S. R., ASAKA, M., HOLLOSZY, J. O. & HAN, D. H. 2013. Effects of resveratrol and SIRT1 on PGC-1alpha activity and mitochondrial biogenesis: a reevaluation. PLoS Biol, 11, e1001603.

S23
FANG, E. F., KASSAHUN, H., CROTEAU, D. L., SCHEIBYE-KNUDSEN, M., MAROSI, K., LU, H., SHAMANNA, R. A., KALYANASUNDARAM, S., BOLLINENI, R. C., WILSON, M. A., ISER, W. B., WOLLMAN, B. N., MOREVATI, M., LI, J., KERR, J. S., LU, Q., WALTZ, T. B., TIAN, J., SINCLAIR, D. A., MATTSON, M. P., NILSEN, H. & BOHR, V. A. 2016. NAD(+) Replenishment Improves Lifespan and Healthspan in Ataxia Telangiectasia Models via Mitophagy and DNA Repair. Cell Metab, 24, 566-581.

S24
FANG, E. F., KASSAHUN, H., CROTEAU, D. L., SCHEIBYE-KNUDSEN, M., MAROSI, K., LU, H., SHAMANNA, R. A., KALYANASUNDARAM, S., BOLLINENI, R. C., WILSON, M. A., ISER, W. B., WOLLMAN, B. N., MOREVATI, M., LI, J., KERR, J. S., LU, Q., WALTZ, T. B., TIAN, J., SINCLAIR, D. A., MATTSON, M. P., NILSEN, H. & BOHR, V. A. 2016. NAD(+) Replenishment Improves Lifespan and Healthspan in Ataxia Telangiectasia Models via Mitophagy and DNA Repair. Cell Metab, 24, 566-581.


Calibration

S1
BAI, P., CANTO, C., OUDART, H., BRUNYANSZKI, A., CEN, Y., THOMAS, C., YAMAMOTO, H., HUBER, A., KISS, B., HOUTKOOPER, R. H., SCHOONJANS, K., SCHREIBER, V., SAUVE, A. A., MENISSIER-DE MURCIA, J. & AUWERX, J. 2011. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab, 13, 461-468.

S2
CANTO, C., GERHART-HINES, Z., FEIGE, J. N., LAGOUGE, M., NORIEGA, L., MILNE, J. C., ELLIOTT, P. J., PUIGSERVER, P. & AUWERX, J. 2009. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature, 458, 1056-60.

S3
EGAWA, T., OHNO, Y., GOTO, A., IKUTA, A., SUZUKI, M., OHIRA, T., YOKOYAMA, S., SUGIURA, T., OHIRA, Y., YOSHIOKA, T. & GOTO, K. 2014. AICAR-induced activation of AMPK negatively regulates myotube hypertrophy through the HSP72-mediated pathway in C2C12 skeletal muscle cells. Am J Physiol Endocrinol Metab, 306, E344-54.

S4
CANTO, C., JIANG, L. Q., DESHMUKH, A. S., MATAKI, C., COSTE, A., LAGOUGE, M., ZIERATH, J. R. & AUWERX, J. 2010. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab, 11, 213-9.

S5
CANTO, C., HOUTKOOPER, R. H., PIRINEN, E., YOUN, D. Y., OOSTERVEER, M. H., CEN, Y., FERNANDEZ-MARCOS, P. J., YAMAMOTO, H., ANDREUX, P. A., CETTOUR-ROSE, P., GADEMANN, K., RINSCH, C., SCHOONJANS, K., SAUVE, A. A. & AUWERX, J. 2012. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab, 15, 838-47.










JACKSON, M. F., HOVERSTEN, K. E., POWERS, J. M., TROBRIDGE, G. D. & RODGERS, B. D. 2013. Genetic manipulation of myoblasts and a novel primary myosatellite cell culture system: comparing and optimizing approaches. FEBS J, 280, 827-39.



YANG, N. C., SONG, T. Y., CHANG, Y. Z., CHEN, M. Y. & HU, M. L. 2015. Up-regulation of nicotinamide phosphoribosyltransferase and increase of NAD+ levels by glucose restriction extend replicative lifespan of human fibroblast Hs68 cells. Biogerontology, 16, 31-42.
